# Passage Bio (PASG) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/PASG
## Company Profile
- Ticker: PASG
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Gene Therapy, CNS
## Stock Data
- Close: 4.75 USD
- Market cap: 18910039.95 USD
- Last updated: 2026-09-03
## Business Overview
Passage Bio is a gene-therapy company focused on rare and neurological diseases. Its business has centered on the challenge of translating genetic medicine into the central nervous system.
## Why The Stock Is Moving

As of Sep 3, 2026, PASG closed up 3.04% at $4.75. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, Passage sits in advanced biotechnology.

## Business Model

The company depends on clinical data, delivery science, and the ability to create value in rare genetic disease.

## Landscape Position

Passage is a high-catalyst gene-therapy name whose valuation is tied to early clinical outcomes.

## Future Catalysts

- Passage Bio’s catalysts are its rare-CNS gene-therapy programs and any strategic update that clarifies which assets still matter. The company needs stronger clinical clarity.

## Recent News
- 2026-06-24 20:05 EST — [Passage Bio and Remix Therapeutics Announce Merger Agreement](https://biopharmsignal.com/news/PASG/passage-bio-and-remix-therapeutics-announce-merger-agreement-8fb9a1f7) — Source: Passage Bio
- 2026-04-20 11:00 EST — [Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates](https://biopharmsignal.com/news/PASG/passage-bio-reports-updated-interim-data-from-uplift-d-trial-and-provides-regulatory-and-corporate-updates) — Source: Passage Bio
- 2026-03-03 12:00 EST — [Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights](https://biopharmsignal.com/news/PASG/passage-bio-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-recent-business-highlights) — Source: Passage Bio
- 2026-02-19 12:00 EST — [Passage Bio to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/PASG/passage-bio-to-participate-in-upcoming-investor-conferences) — Source: Passage Bio
- 2025-11-10 21:15 EST — [Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights](https://biopharmsignal.com/news/PASG/passage-bio-reports-third-quarter-2025-financial-results-and-provides-recent-business-highlights) — Source: Passage Bio